Cancer Immunotherapy Is Fastest Growing Segment Fueling Growth Of Oncology Drug Pipeline Analysis Market
Oncology Drug Pipeline Analysis Market The oncology drug pipeline analysis market consists of various therapeutic drugs and molecules which are under clinical trial phases for effective treatment of different types of cancers. These drugs aim to improve survival rates, reduce side effects and provide better quality of life to cancer patients. The global Oncology Drug Pipeline Analysis Market is estimated to be valued at US$ 188.20 Bn in 2023 and is expected to exhibit a CAGR of 13. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Cancer immunotherapy is one of the key trends contributing to the growth of the oncology drug pipeline analysis market. Immunotherapy helps boost patient's immune system to fight cancer cells more effectively. Various new immunotherapy treatments such as immune checkpoint inhibitors, T-cell therapies etc. are under pipeline which may help in long term remission for ...